The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Emperor Energy (EMP) receives firm commitments to undertake a $1.5 million share placement
  • A total of 35.3 million new fully-paid ordinary shares will now be issued to professional and sophisticated investors at 4.25 cents
  • Additionally, Emperor intends to settle creditors with the allocation of 2.24 million new fully-paid ordinary shares at an issue price of 4.25 cents for a total value of $95,200
  • Once received, Emperor will use the money from the placement to strengthen its balance sheet and fund its upcoming exploration activities
  • Shares in Emperor were down two per cent to end the day, down to 4.9 cents

Emperor Energy (EMP) has received firm commitments to undertake a $1.5 million share placement.

The company entered a trading halt on February 1 but did not disclose how much it intended to raise or what it would use the funds for once received.

A total of 35.3 million new fully-paid ordinary shares will now be issued to professional and sophisticated investors at 4.25 cents.

This price represents a 15 per cent discount to Emperor’s five-day volume-weighted average price of five cents and a 15 per cent discount to the last trading price of five cents.

Additionally, Emperor intends to settle creditors with the allocation of 2.24 million new fully-paid ordinary shares at an issue price of 4.25 cents for a total value of $95,200.

Subject to the receipt of funds, the shares will be issued on or around February 5.

Once received, Emperor will use the money from the placement to strengthen its balance sheet and fund its upcoming exploration activities.

Shares in Emperor were down two per cent to end the day, down to 4.9 cents.

EMP by the numbers
More From The Market Online
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next
The words "Market Open" appear stacked atop one another next to ASX company iconography.

ASX Market Open: Ever-extending US loss streak to bleed into red Friday – unless Oz bucks trend again | Jan 3, 2024

The ASX 200 is expected to open 0.07% lower at 8,185 points, though after